Liver cancer incidence is rising, for a variety of reasons including viral infections and lifestyle. Primary liver cancer is a challenging condition to diagnose and treat, in part because many cases of liver cancer are diagnosed when the condition is already advanced and surgical treatment no longer offers a cure.
That is when Yale Medicine becomes involved. The doctors at Yale Interventional Radiology and Interventional Oncology at Smilow use cutting-edge image guidance for precise, minimally invasive treatments of liver cancer. According to Kevin Kim, MD, chief of Yale Medicine Interventional Radiology and Interventional Oncology at Smilow Cancer Hospital, "The majority of patients with liver cancer benefit, in terms of overall survival and quality of life, from precision-targeted interventional treatments."